Pramodini Medicare IPO GMP is an important metric investors may track ahead of the company's proposed NSE SME listing. Pramodini Medicare IPO is a book-built issue of ₹69.04 crore, comprising a fresh issue and an offer for sale.
The IPO opened for subscription on August 12, 2026, and closed on August 14, 2026. The allotment is expected to be finalized on August 17, 2026, while the tentative listing date is August 19, 2026 on the NSE SME platform.
The IPO has a price band of ₹110 to ₹118 per share, with a lot size of 1,200 shares. At the upper price band, the minimum retail investment is ₹2,83,200, while the minimum HNI application requires 3 lots, or 3,600 shares, amounting to ₹4,24,800.
.webp)
The Pramodini Medicare IPO GMP represents the premium or discount at which the IPO shares are reportedly traded in the unofficial grey market before their stock-market listing.
GMP is not an official exchange price and can change based on market sentiment, IPO demand, subscription trends and broader market conditions.
Investors should therefore use the latest available GMP only as an indicative sentiment indicator and not as a guaranteed prediction of the listing price.
Pramodini Medicare IPO GMP Calculation
The indicative listing price can be calculated by adding the GMP to the upper end of the IPO price band.
Estimated Listing Price = IPO Price + GMP
For example, if the GMP is ₹20 and the upper issue price is ₹118:
₹118 + ₹20 = ₹138
The indicative gain would be:
₹20 ÷ ₹118 × 100 = approximately 16.95%
This calculation is purely illustrative. The actual listing price may differ substantially from the GMP-based estimate.
Pramodini Medicare IPO Overview
Pramodini Medicare IPO is a book-built issue of ₹69.04 crore.
The issue consists of:
Fresh Issue: 0.54 crore shares aggregating to ₹63.14 crore
Offer for Sale: 0.05 crore shares aggregating to ₹5.90 crore
Total Issue Size: ₹69.04 crore
The fresh issue component will provide funds to the company, while proceeds from the offer-for-sale component will go to the selling shareholders, subject to the applicable issue expenses and terms.
Pramodini Medicare IPO Important Dates
The key dates investors should note are:
The allotment and listing dates are tentative and investors should check the latest official updates from the company, registrar and exchange.
Pramodini Medicare IPO Price Band and Lot Size
The IPO price band has been fixed at ₹110 to ₹118 per share.
The lot size is 1,200 shares.
At the upper price band of ₹118, one lot represents an investment of:
1,200 × ₹118 = ₹1,41,600
For retail investors, the minimum application is 2 lots, or 2,400 shares.
Therefore, the minimum retail investment at the upper price band is:
2,400 × ₹118 = ₹2,83,200
For HNI investors, the minimum application is 3 lots, or 3,600 shares.
The minimum HNI investment at ₹118 is:
3,600 × ₹118 = ₹4,24,800
Pramodini Medicare IPO Issue Structure
The ₹69.04 crore IPO consists of both a fresh issue and an offer for sale.
Fresh Issue
The fresh issue comprises 0.54 crore shares, aggregating to approximately ₹63.14 crore. The proceeds from the fresh issue will be available to the company for its stated objectives after applicable issue expenses.
Offer for Sale
The IPO also includes an offer for sale of 0.05 crore shares, aggregating to approximately ₹5.90 crore.
In an OFS, the proceeds from the shares sold generally go to the existing selling shareholders rather than the company.
Pramodini Medicare IPO GMP and Listing Price
Investors often compare the IPO price with the GMP to estimate a possible listing price.
Suppose the latest GMP is ₹15:
IPO Upper Price = ₹118
Estimated Listing Price = ₹118 + ₹15 = ₹133
Indicative Gain = ₹15 per share
For one retail application of 2,400 shares, the theoretical gain at this hypothetical GMP would be:
2,400 × ₹15 = ₹36,000
However, this is only a mathematical illustration. GMP can change before listing, and the actual listing price is determined by market forces.
Why Is Pramodini Medicare IPO GMP Important?
The Pramodini Medicare IPO GMP can provide an indication of short-term grey-market sentiment toward the issue.
A rising GMP may indicate increasing unofficial demand, while a declining GMP can indicate weakening sentiment. However, GMP should always be considered alongside:
IPO subscription figures
Company's financial performance
Valuation
Industry outlook
Market conditions
Promoter and shareholder structure
SME liquidity risks
GMP alone cannot determine whether an IPO is fundamentally attractive.
Pramodini Medicare IPO Allotment
The Pramodini Medicare IPO allotment is expected to be finalized on August 17, 2026.
After allotment, investors can check their application status through the IPO registrar or other official channels.
Investors who receive an allotment should see the shares credited to their demat accounts before the proposed listing date, subject to the applicable IPO processing schedule.
Pramodini Medicare IPO Listing Date
Pramodini Medicare IPO is proposed to list on the NSE SME platform.
The tentative listing date is August 19, 2026.
The actual opening price can differ from both the issue price and any prevailing grey-market premium. SME shares can also experience significant price movements after listing because of liquidity and market-demand conditions.
Pramodini Medicare IPO: Fresh Issue vs OFS
Understanding the issue structure is important for investors.
A large portion of the issue consists of fresh shares, meaning most of the IPO proceeds are intended to be raised by the company rather than existing shareholders.
Pramodini Medicare IPO Strengths
Investors evaluating the IPO may consider the following factors:
The majority of the issue comprises a fresh issue.
The IPO provides the company with access to public capital.
The company is entering the SME capital market to support its future business objectives.
The book-building structure allows price discovery within the specified price band.
Investors can evaluate the company based on its financial performance, business model and healthcare-sector prospects.
Pramodini Medicare IPO Risks
Investors should also consider the potential risks.
SME Market Risk
NSE SME-listed stocks can have lower liquidity compared with main-board stocks. This can make it more difficult to buy or sell shares at the desired price.
GMP Volatility
Grey-market premiums are unofficial and can change quickly. A positive GMP does not guarantee listing gains.
Healthcare Industry Risks
Healthcare businesses can be affected by regulatory changes, competition, operating costs, demand fluctuations and changes in the broader healthcare environment.
Valuation Risk
Investors should compare the IPO valuation with comparable listed companies and the company's earnings before making an investment decision.
Pramodini Medicare IPO: Should You Apply?
The Pramodini Medicare IPO offers investors an opportunity to participate in an SME healthcare-related company through a ₹69.04 crore public issue.
The IPO has a price band of ₹110 to ₹118 and requires a minimum retail investment of ₹2.83 lakh at the upper price band. This is a substantial investment amount, so investors should carefully assess the company's fundamentals and risk profile.
The Pramodini Medicare IPO GMP can be monitored for market sentiment, but investors should not rely on GMP alone. Financial performance, valuation, business prospects, IPO objectives and SME-market risks are equally important.
Pramodini Medicare IPO FAQs
What is Pramodini Medicare IPO GMP?
Pramodini Medicare IPO GMP is the unofficial premium or discount at which the IPO shares may be traded in the grey market before their official listing. It is not an official exchange indicator and can change frequently.
What is the Pramodini Medicare IPO price band?
The IPO price band is ₹110 to ₹118 per share.
What is the Pramodini Medicare IPO lot size?
The IPO lot size is 1,200 shares.
What is the minimum retail investment?
Retail investors need to apply for at least 2 lots, or 2,400 shares. At the upper price of ₹118, the minimum investment is ₹2,83,200.
What is the minimum HNI investment?
The minimum HNI application is 3 lots, or 3,600 shares, requiring ₹4,24,800 at the upper price band.
When is Pramodini Medicare IPO allotment?
The allotment is expected to be finalized on August 17, 2026.
When will Pramodini Medicare IPO list?
The tentative listing date is August 19, 2026, on the NSE SME platform.
What is the Pramodini Medicare IPO issue size?
The total issue size is ₹69.04 crore, consisting of a ₹63.14 crore fresh issue and a ₹5.90 crore offer for sale.
Conclusion
Pramodini Medicare IPO is a ₹69.04 crore book-built SME IPO comprising a fresh issue of ₹63.14 crore and an offer for sale of ₹5.90 crore. The IPO price band is ₹110 to ₹118 per share, with a lot size of 1,200 shares.
The IPO closed on August 14, 2026, with allotment expected on August 17 and a tentative NSE SME listing on August 19, 2026.
The Pramodini Medicare IPO GMP can help investors understand unofficial market sentiment ahead of the listing, but it should only be treated as an indicative metric. Investors should conduct comprehensive fundamental and valuation analysis before deciding whether the IPO is suitable for their investment objectives.
About Finowings: Finowings provides IPO information, financial market insights and investment-related educational content to help investors understand public issues and market developments.
Disclaimer: IPO GMP is unofficial and may change at any time. It does not guarantee the actual listing price or future returns. This content is provided for informational and educational purposes only and should not be considered investment advice. Investors should conduct their own research or consult a qualified financial adviser before making investment decisions.
Post a Comment